Potent opioid peptide agonists containing 4′-[N-((4′-phenyl)- phenethyl)carboxamido]phenylalanine (Bcp) in place of Tyr

Chemical Biology and Drug Design

Volumn 72, Issue 5, 2008, Pages 337-340

  Weltrowska, Grazyna ^a   Nguyen, Thi M D ^a   Lemieux, Carole ^a   Chung, Nga N ^a   Schiller, Peter W ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

4 N ((4 phenyl) phenethyl)carboxamido phenylalanine; Opioid activity profiles; Opioid peptide analogues; Opioid peptide SAR; Peptide synthesis

Indexed keywords

4' [N ((4' PHENYL) PHENETHYL)CARBOXAMIDO]PHENYLALANINE; ALANINE DERIVATIVE; ARGININE; CYCLAZOCINE; CYCLOPEPTIDE; DYNORPHIN; MU OPIATE RECEPTOR; OPIATE PEPTIDE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SYNTHESIS; RECEPTOR BINDING;

ANIMALS; CELLS, CULTURED; GUINEA PIGS; INHIBITORY CONCENTRATION 50; MICE; NEUROTRANSMITTER AGENTS; OPIOID PEPTIDES; PEPTIDES, CYCLIC; PHENYLALANINE; PROTEIN CONFORMATION; RECEPTORS, OPIOID, MU;

EID: 54249130705     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00720.x     Document Type: Article

References (21)

1. Morgan B.A., Smith C.F., Waterfield A.A., Hughes J., Kosterlitz H.W. (1976) Structure-activity relationships of methionine-enkephalin. J Pharm Pharmacol 28 : 660 661.
2. Ling N., Guillemin R. (1976) Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs. Proc Natl Acad Sci USA 73 : 3308 3310.
3. 5]enkephalin. J Med Chem 35 : 684 687.
4. Dolle R.E., Machaut M., Martinez-Teipel B., Belanger S., Cassel J.A., Stabley G.J., Graczyk T.M., DeHaven R.N. (2004) (4-Carboxamido)phenylalanine is a surrogate for tyrosine in opioid receptor peptide ligands. Bioorg Med Chem Lett 14 : 3545 3548.
5. 1 are potent opioid agonists. J Pept Res 65 : 36 41.
6. Wentland M.P., Lou R., Ye Y., Cohen D.J., Richardson G.P., Bidlack J.M. (2001) 8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Bioorg Med Chem Lett 11 : 623 626.
7. Le Bourdonnec B., Belanger S., Cassel J.A., Stabley G.J., DeHaven R.N., Dolle R.E. (2003) trans-3,4-Dimethyl-4-(3-carboxamidophenyl)piperidines: a novel class of μ-selective opioid antagonists. Bioorg Med Chem Lett 13 : 4459 4462.
8. Zhang A., Xiong W., Bidlack J.M., Hilbert J.E., Knapp B.I., Wentland M.P., Neumeyer J.L. (2004) 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed κ and μ opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors. J Med Chem 47 : 165 174.
9. Wentland M.P., VanAlstine M., Kucejko R., Lou R., Cohen D.J., Parkhill A.L., Bidlack J.M. (2006) Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-((4′-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine. J Med Chem 49 : 5635 5639.
10. VanAlstine M.A., Wentland M.P., Cohen D.J., Bidlack J.M. (2007) Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 5. Opioid receptor binding properties of N-((4′-phenyl)-phenethyl) analogues of 8-CAC. Bioorg Med Chem Lett 17 : 6516 6520.
11. Schiller P.W., Nguyen T.M.-D., DiMaio J., Lemieux C. (1983) Comparison of μ-, δ- and κ-receptor binding sites through pharmacologic evaluation of p-nitrophenylalanine analogs of opioid peptides. Life Sci 33 (Suppl 1 319 322.
12. Schiller P.W., Nguyen T.M.-D., Chung N.N., Lemieux C. (1989) Dermorphin analogues carrying an increased positive net charge in their 'message' domain display extremely high mu opioid receptor selectivity. J Med Chem 32 : 698 703.
13. Lu Y., Nguyen T.M.-D., Weltrowska G., Berezowska I., Lemieux C., Chung N.N., Schiller P.W. (2001) [2′,6′-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective κ opioid antagonists. J Med Chem 44 : 3048 3053.
14. Paton W.D.M. (1957) The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Br J Pharmacol 12 : 119 127.
15. Henderson G., Hughes J., Kosterlitz H.W. (1972) A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol 46 : 764 766.
16. Schiller P.W., Lipton A., Horrobin D.F., Bodanszky M. (1978) Unsulfated C-terminal 7-peptide of cholecystokinin: a new ligand of the opiate receptor. Biochem Biophys Res Commun 85 : 1332 1338.
17. DiMaio J., Nguyen T.M.-D., Lemieux C., Schiller P.W. (1982) Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogues: effect of conformational constraints on opiate receptor selectivity. J Med Chem 25 : 1432 1438.
18. 65-analogue. Comparison of the binding properties of methionine- and leucine-enkephalin. Eur J Pharmacol 58 : 11 18.
19. 50) of an enzymatic reaction. Biochem Pharmacol 22 : 3099 3108.
20. Schiller P.W., Nguyen T.M.-D., Berezowska I., Dupuis S., Weltrowska G., Chung N.N., Lemieux C. (2000) Synthesis and in vitro opioid activity profiles of DALDA analogues. Eur J Med Chem 35 : 895 901.
21. Kenakin T. (2007) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28 : 407 415.